The 11β-hydroxyandrostenedione pathway and C11-oxy C<sub>21</sub> backdoor pathway are active in benign prostatic hyperplasia yielding 11keto-testosterone and 11keto-progesterone.
作者:
关键词
11keto-dihydroprogesterone (11KDHPROG, 11KDHP4, 5α-pregnan-3,11,20-trione)11keto-dihydrotestosterone (11KDHT, 5α-androstan-17β-ol-3,11-dione)Adrenal steroid precursorsCastration resistant prostate cancer (CRPC)Cytochrome P450 17α-hydroxylase/17,20 lyase (CYP17A1, P450 c17)UPC(2)-MS/MS (Ultra-performance convergence chromatography tandem mass spectrometry)
主题词
雄烯二酮(Androstenedione);细胞, 培养的(Cells, Cultured);人类(Humans);男(雄)性(Male);代谢网络和途径(Metabolic Networks and Pathways);孕酮(Progesterone);前列腺增生(Prostatic Hyperplasia);甾类(Steroids);睾酮(Testosterone)
DOI
10.1016/j.jsbmb.2019.105497
PMID
31626910
发布时间
2020-06-30
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文